Role of the M2 Subunit of Ribonucleotide Reductase in Regulation by Hydroxyurea of the Activity of the Anti-HIV-1 Agent 2′,3′-Dideoxyinosine
- 1 July 1998
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 56 (1) , 105-112
- https://doi.org/10.1016/s0006-2952(98)00127-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Anti-HIV Activity of the Combination of Didanosine and Hydroxyurea in HIV-1-Infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
- Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes.Proceedings of the National Academy of Sciences, 1994
- Hydroxyurea as an Inhibitor of Human Immunodeficiency Virus-Type 1 ReplicationScience, 1994
- Suppression of HIV production in resting lymphocytes by combining didanosine and hydroxamate compoundsThe Lancet, 1994
- Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.Journal of Clinical Investigation, 1993
- S-Phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAsBiochemistry, 1990
- Hydroxyurea increases the phosphorylation of 3′‐fluorothymidine and 3′‐azidothymidine in CEM cellsEuropean Journal of Biochemistry, 1989
- Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primersAnalytical Biochemistry, 1989
- Identification of purine deoxyribonucleoside kinases from human leukemia cells: substrate activation by purine and pyrimidine deoxyribonucleosidesBiochemistry, 1987
- [20] Cell synchronizationPublished by Elsevier ,1979